Abstract
Introduction

Human T lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) typically manifests with slow onset and chronic and steady progression of myelopathic deficits (1). The acute onset and rapid progression of myelopathy has been termed acute HAM or rapidly progressive HAM
. Although multiple periventricular lesions were apparent on brain MRI ( Fig. 2A) , a neurologist considered the patient to be suffering from HAM. He underwent steroid-pulse therapy consisting of 1,000 mg/day intravenous methylprednisolone for three consecutive days, followed by 3MIU/day interferon-α (Sumiferon
F i g u r e 1 . T h o r a c i c c o r d MRI a t a g e 5 6 . T 2 -we i g h t e d i ma g e s ( A: s a g i t t a l i ma g e , B : a x i a l i ma g e a t t h e T 4 v e r t e b r a l l e ve l ) s h o we d a l o n g c o r d l e s i o n wh i c h wa s c e n t r a l l y l o c a t e d wi t h o b s c u r e g a d o l i n i u m-e n h a n c e me n t ( C: s a g i t t a l i ma g e , D: a x i a l i ma g e a t t h e T 4 v e r t e b r a l l e v e l ) .
F i g u r e 2 . B r a i n MRI a t a g e 5 6 ( A) a n d a g e 5 9 ( B a n d C) . T 2 -we i g h t e d i ma g e s h o we d mu l t i p l e p e r i v e n t r i c u l a r h y p e r i nt e n s e a r e a s a t a g e 5 6 ( A) a n d a g e 5 9 ( B ) . No t e t h a t t h e l e s i o n s we r e i n c r e a s e d , e s p e c i a l l y a t t h e s p l e n i u m ( a r r o w) a n d t r u n k ( a r r o wh e a d ) o f t h e c o r p u s c a l l o s u m a t a g e 5 9 . T h e b r a i n a l s o a p p e a r e d s l i g h t l y a t r o p h i c a n d o v o i d l e s i o n s we r e p r e s e n t a t a g e 5 9 .
three years, and his myelopathic symptoms showed slow but steady recovery in this period.
At (Fig. 2B, 2C) (12) . Previous case reports of "acute HAM" (2, 3) and "HAM with relapsing cervical cord lesions" (13) (1, 8) .
Discussion
The present patient experienced four attacks of optic neuritis or myelitis, with indications of HTLV-1 infection. Multiple and increasing brain lesions, predominantly in the corpus callosum, suggested conventional MS. In both HAM and MS, an oligoclonal IgG band in the CSF, and brain lesions on MRI may be present (1, 6). With acute HAM, in which myelopathic deficits rapidly progress (2, 3), it is difficult to differentiate MS from HAM, especially in areas endemic for HTLV-1 infection. This difficulty is largely due to the lack of laboratory markers specific for HAM or MS. Thus, the etiological position of MS with HTLV-1 antibody remains unclear (6), and it is debatable whether HTLV-1 infection is related to MS development (7). Serum anti-AQP4 antibody was recently identified as a specific laboratory marker for NMO (8). Clinical and immunological characteristics indicate that NMO is a distinct dis-ease entity from MS (8). It remains controversial whether
